kaletra.com Report : Visit Site

Technical data of the kaletra.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host kaletra.com. Currently, hosted in United Kingdom and its service provider is Rackspace Ltd. .

the related websites

aidsmap.com i-base.info revealtrial.org tht.org.uk dulera.com lmsg.nhs.uk lekarinfo.com hse.gov.uk marksandspencer.com bath.ac.uk publicstorage.com visitlondon.com whc.unesco.org fedex.com nbcbayarea.com maccosmetics.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/8.5 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

important safety information prescribing information medication guide my journey with kaletra starts today kaletra is a prescription medicine that is used with other antiviral medicines to treat human immunodeficiency virus-1 (hiv-1) infection in adults and children 14 days of age and older. hiv is the virus that causes aids (acquired immune deficiency syndrome). it is not known if kaletra is safe and effective in children under 14 days old. kaletra is not a cure for hiv-1 infection. people taking kaletra may continue to experience illnesses associated with hiv-1 infection, including opportunistic infections. get instant savings kaletra savings program save up to $400 per month with a $4,800 per year maximum for eligible patients † † eligibility: available to patients with commercial prescription insurance coverage for kaletra who meet eligibility criteria. copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, medicare [including part d], medicare advantage, medigap, medicaid, tricare, department of defense, or veterans affairs programs) or where prohibited by law or by the patient's health insurance provider. if at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the kaletra savings card and patient must call opus health at 800.364.4767 to stop participation. patients residing in or receiving treatment in certain states may not be eligible. patients may not seek reimbursement for value received from the kaletra savings program from any third-party payers. offer subject to change or discontinuance without notice. restrictions, including monthly maximums, may apply. this is not health insurance. please see full terms and conditions. model is for illustrative purposes only. for more information on kaletra savings program patients: call 1-800-441-4987 - opt 5 pharmacists: call opus health at 1-800-364-4767 for instructions and assistance patient instructions: present this kaletra savings offer along with your insurance card when presenting your prescription save up to $400 a month on qualified prescriptions some mail-order pharmacies may have other requirements please contact your mail-order pharmacist for redemption instructions terms and conditions pharmacist instructions: submit the copay card authorized for all commercially insured patients by the patient's primary insurance as a secondary transaction to opus health. when you use this card, you are confirming that you have not submitted and will not submit a claim for this prescription for reimbursement under any federal, state or government-funded healthcare program, such as medicare (including part d), medicare advantage, medicaid, medigap, veterans affairs, the department of defense or tricare. pharmacists with questions please call opus health at 800.364.4767. this offer may be changed or discontinued without notice. abbvie medical information 1.800.633.9110 www.abbviemedinfo.com abbvie patient assistance foundation 1.800.222.6885 www.abbviepaf.org what is kaletra ® (lopinavir/ritonavir) tablets and oral solution? kaletra is a prescription medicine that is used with other antiviral medicines to treat human immunodeficiency virus-1 (hiv-1) infection in adults and children 14 days of age and older. hiv is the virus that causes aids (acquired immune deficiency syndrome). it is not known if kaletra is safe and effective in children under 14 days old. important safety information 1 what is the most important information i should know about kaletra? kaletra may cause serious side effects, including: interactions with other medicines. it is important to know the medicines that should not be taken with kaletra. for more information, see "who should not take kaletra?" side effects in babies taking kaletra oral solution. kaletra oral solution contains alcohol (ethanol) and propylene glycol. call your healthcare provider right away if your baby appears too sleepy or their breathing changes. inflammation of your pancreas (pancreatitis). kaletra can cause pancreatitis, which may be serious and may lead to death. people who have high levels of a certain fat (triglycerides) have a risk for developing pancreatitis. if you have advanced hiv-1 disease, you may have an increased risk of high triglyceride levels in your blood and pancreatitis. if you have a history of pancreatitis, you may have an increased risk of it recurring during treatment with kaletra. tell your healthcare provider if you have any signs or symptoms of pancreatitis including nausea, vomiting, and/or stomach area (abdominal) pain. liver problems. liver problems, including death, can happen in people who take kaletra. your healthcare provider should do blood tests before and during your treatment with kaletra to check your liver function. if you have hepatitis b, hepatitis c, or other liver problems, you may have an increased risk for developing new or worsening liver problems during treatment with kaletra. tell your healthcare provider right away if you have any signs or symptoms of liver problems including loss of appetite, yellowing of skin or eyes (jaundice), dark-colored urine, pale-colored stools, itchy skin, and/or stomach area (abdominal) pain. changes in your heart rhythm and the electrical activity of your heart can occur when taking kaletra. these changes can lead to serious heart problems. your risk for these problems may be higher if you already have a history of abnormal heart rhythm or other types of heart problems, or if you take other medicines that can affect your heart rhythm while you take kaletra. tell your healthcare provider right away if you experience dizziness, lightheadedness, fainting, and/or a sensation of abnormal heartbeats. see "what are the possible side effects of kaletra?" for more information about serious side effects. who should not take kaletra? do not take kaletra if you are allergic to lopinavir, ritonavir or any ingredients in kaletra. do not take kaletra if you take any of the following medicines: alfuzosin (uroxatral ® ); cisapride (propulsid ® , propulsid quicksolv ® ); colchicine (colcrys ® , col-probenecid ® , mitigare ® ), if you have kidney or liver problems; dronedarone (multaq ® ); elbasvir/grazoprevir (zepatier ® ); ergot containing medicines, including ergotamine tartrate (cafergot ® , ergomar ® , ergostat ® , ergotamine ® , medihaler ® , migergot ® , wigraine ® , wigrettes ® ), dihydroergotamine mesylate (d.h.e. 45 ® or migranal ® ), and methylergonovine (methergine ® ); lovastatin (altoprev ® or mevacor ® ); midazolam, when taken by mouth; lurasidone (latuda ® ); pimozide (orap ® ); ranolazine (ranexa ® ); rifampin (rifadin ® , rifamate ® , rifater ® , or rimactane ® ); sildenafil (revatio ® ), when used for the treatment of pulmonary arterial hypertension; simvastatin (zocor ® , vytorin ® ); st. john's wort ( hypericum perforatum ); or triazolam (halcion ® ). serious problems can happen if you or your child takes any of the medicines listed above with kaletra. what should i tell my doctor before taking kaletra? tell your doctor about all of your medical conditions, including if you have any heart problems, including if you have a condition called congenital long qt syndrome; have or had pancreas problems, liver problems, including hepatitis b or hepatitis c, diabetes, hemophilia (people who take kaletra may have increased bleeding), low potassium in your blood; or are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. if you take kaletra during pregnancy, you should talk with your doctor about how you can take part in an antiretroviral pregnancy registry . kaletra oral solution contains alcohol (ethanol) and propylene glycol. you should not take kaletra oral solution during pregnancy because there is no safe level of alcoh

URL analysis for kaletra.com

http://www.kaletra.com/#isi
http://www.kaletra.com/pdf/copay_card.pdf
http://www.kaletra.com/#kaletra

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: KALETRA.COM
Registry Domain ID: 25338862_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2018-03-19T09:18:55Z
Creation Date: 2000-04-20T16:13:23Z
Registry Expiry Date: 2019-04-20T16:13:23Z
Registrar: MarkMonitor Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: ABVEGDMZNS1.ABBVIE.COM
Name Server: ABVLUDMZNS1.ABBVIE.COM
Name Server: ABVSGDMZNS1.ABBVIE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-06-01T06:36:06Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR MarkMonitor Inc.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =kaletra.com

  PORT 43

  TYPE domain

DOMAIN

  NAME kaletra.com

  CHANGED 2018-03-19

  CREATED 2000-04-20

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  ABVEGDMZNS1.ABBVIE.COM 159.180.132.57

  ABVLUDMZNS1.ABBVIE.COM 159.180.162.57

  ABVSGDMZNS1.ABBVIE.COM 159.180.178.57

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .